We provide complete regulatory compliance solutions for homeopathic medicines in the USA.
We assist startups and existing companies with FDA NDC Labeler Code Requests, US Drug Listing (DRLS), Label Compliance, Drug Facility Registration and Annual Registration Renewal. Get the information and guidance you need to meet all regulatory requirements and obtain NDC labeler codes for your drug products.
Drugs are recognized and reported using a unique, three-segment number assigned by the FDA. This three-segment number is called the National Drug Code (NDC labeler code) and serves as the FDA’s identifier for drugs. The NDC labeler code also helps consumers and compliance enforcement experts to identify medicines sold in the USA.
Further, NDC labeler codes identify the pharmaceutical firm, repackager, or distributor as well as the type of drug product with the active ingredient and the package type and size. Any product that has been classified as a drug and is marketed without an NDC does not cater to the FDA’s requirements and is considered to pose a risk to consumers/patients.
Proven Expertise. Companies that have put their faith in us to help them comply with the regulations.
No drug products, including homeopathic medicines, in the USA can be sold without meeting the applicable drug product regulations. Drugs without an NDC Labeler Code mean the FDA has not reviewed them for safety and effectiveness.
According to this Act, every registered Drug Establishment must provide the FDA with a list of drugs they currently manufacture, propagate, prepare, or process for commercial sale or distribution.
The FDA publishes the listed NDC Labeler Code numbers in the NDC Directory, which has information on active and certified finished drug products. The FDA updates this directory daily.
We provide quick assistance at the right time to help you meet homeopathic drug regulations in the USA. Our range of homeopathic drug compliance solutions for the USA includes: We help clients adhere to US Drug Label Regulations for homeopathic medicines by making them aware of any labelling requirements and changes. We provide assistance with managing your establishment registrations, followed by submitting an application to the FDA.
In a letter issued February 5, 2026, the U.S. Food and Drug Administration (FDA) said it intends to exercise enforcement discretion when food manufacturers use
... Read more
Health Canada has opened a public consultation on a new prebiotics monograph, with stakeholder feedback accepted until February 20, 2026. The draft guidance, released by the Natural
... Read more
Health Canada has confirmed that Sports Electrolyte Supplements will be reclassified under a single regulatory framework, marking a significant change for products currently regulated as either natural
... Read more
On January 23, 2026, the U.S. Food and Drug Administration (FDA) announced new actions aimed at improving how a gluten ingredient is disclosed on food labels. The update, released on January
... Read more
